Loading data
MDANYSE
| Unit: CAD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.63 bn CAD | 1.08 bn CAD | 807.6 m CAD | 641.2 m CAD | 476.9 m CAD |
| Cost of revenue | 1.17 bn CAD | 754.6 m CAD | 532 m CAD | 389.1 m CAD | 285.6 m CAD |
| Gross profit | 464.6 m CAD | 325.5 m CAD | 275.6 m CAD | 252.1 m CAD | 191.3 m CAD |
| Research and development expense | 47.1 m CAD | 43.4 m CAD | 44.1 m CAD | 36.1 m CAD | 25.7 m CAD |
| Selling, general and administrative expense | 167.3 m CAD | 127.9 m CAD | 118.1 m CAD | 101.3 m CAD | 92.9 m CAD |
| Operating profit after depreciation | 157.8 m CAD | 106.8 m CAD | 84.2 m CAD | 74.6 m CAD | 18.6 m CAD |
| Operating profit before depreciation | 297.3 m CAD | 197.6 m CAD | 157.5 m CAD | 150.8 m CAD | 98.4 m CAD |
| EBIT | 157.8 m CAD | 106.8 m CAD | 84.2 m CAD | 74.6 m CAD | 18.6 m CAD |
| EBITDA | 297.3 m CAD | 197.6 m CAD | 157.5 m CAD | 150.8 m CAD | 98.4 m CAD |
| Interest expense | 20 m CAD | 41.7 m CAD | 17.5 m CAD | 15.3 m CAD | 26.8 m CAD |
| Profit before tax | 152.4 m CAD | 111 m CAD | 67.3 m CAD | 34.2 m CAD | 11.3 m CAD |
| Income tax expense | 43.9 m CAD | 31.6 m CAD | 18.5 m CAD | 7.9 m CAD | 8.4 m CAD |
| Income before extraordinary items | 108.5 m CAD | 79.4 m CAD | 48.8 m CAD | 26.3 m CAD | 2.9 m CAD |
| Net income (reported basis) | 108.5 m CAD | 79.4 m CAD | 48.8 m CAD | 26.3 m CAD | 2.9 m CAD |
| Basic EPS including extraordinary items | 0.87 CAD/share | 0.66 CAD/share | 0.41 CAD/share | 0.22 CAD/share | 0.03 CAD/share |
| Diluted EPS including extraordinary items | 0.84 CAD/share | 0.63 CAD/share | 0.4 CAD/share | 0.21 CAD/share | 0.02 CAD/share |
| Common dividends | 0 CAD | 0 CAD | 0 CAD | 0 CAD | 0 CAD |
| Total dividends | 0 CAD | 0 CAD | 0 CAD | 0 CAD | 0 CAD |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.